journal article·2024-05Open access

Modulation of Cerebrospinal Fluid Dysregulation via a SPAK and OSR1 Targeted Framework Nucleic Acid in Hydrocephalus

Qiguang Wang, Jian Cheng, Fei Liu, Jianwei Zhu, Yue Li, Yuxuan Zhao, Xiang Li, Huan Zhang, Yan Ju, Lu Ma, Xuhui Hui, Yunfeng Lin

Advanced Science· Volume 11· Issue 17

Abstract

Abstract Hydrocephalus is one of the most common brain disorders and a life‐long incurable condition. An empirical “one‐size‐fits‐all” approach of cerebrospinal fluid (CSF) shunting remains the mainstay of hydrocephalus treatment and effective pharmacotherapy options are currently lacking. Macrophage‐mediated ChP inflammation and CSF hypersecretion have recently been identified as a significant discovery in the pathogenesis of hydrocephalus. In this study, a pioneering DNA nano‐drug (TSOs) is developed by modifying S2 ssDNA and S4 ssDNA with SPAK ASO and OSR1 ASO in tetrahedral framework nucleic acids (tFNAs) and synthesis via a one‐pot annealing procedure. This construct can significantly knockdown the expression of SPAK and OSR1, along with their downstream ion channel proteins in ChP epithelial cells, thereby leading to a decrease in CSF secretion. Moreover, these findings indicate that TSOs effectively inhibit the M0 to M1 phenotypic switch of ChP macrophages via the MAPK pathways, thus mitigating the cytokine storm. In in vivo post‐hemorrhagic hydrocephalus (PHH) models, TSOs significantly reduce CSF secretion rates, alleviate ChP inflammation, and prevent the onset of hydrocephalus. These compelling results highlight the potential of TSOs as a promising therapeutic option for managing hydrocephalus, with significant applications in the future.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cerebrospinal fluid and hydrocephalus · Head and Neck Surgical Oncology · Genetic and Kidney Cyst Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurosurgery West China Hospital Sichuan University Chengdu 610041 P.R. China

Institutes for Systems Genetics Frontiers Science Center for Disease‐Related Molecular Network West China Hospital Sichuan University Chengdu 610041 P.R. China

Department of Neurosurgery Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu 610000 P.R. China

Core facilities West China Hospital Sichuan University Chengdu 610041 P.R. China

State Key Laboratory of Oral Diseases National Center for Stomatology National Clinical Research Center for Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu 610041 P. R. China

Sichuan Provincial Engineering Research Center of Oral Biomaterials Sichuan University Chengdu 610041 P.R. China

National Center for Translational Medicine Shanghai Jiao Tong University Shanghai 200240 P.R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Sichuan Province Youth Science and Technology Innovation Team · Natural Science Foundation of Sichuan Province

References (61)

Show source-provided references
1. 10.1016/S0140-6736(15)60694-810.1016/S0140-6736(15)60694-8 ↗
2. 10.1016/j.cortex.2023.01.00110.1016/j.cortex.2023.01.001 ↗
3. 10.3171/2014.12.JNS13235210.3171/2014.12.JNS132352 ↗
4. 10.1016/j.jpeds.2008.04.06810.1016/j.jpeds.2008.04.068 ↗
5. 10.1016/S0140-6736(15)60694-810.1016/S0140-6736(15)60694-8 ↗
6. 10.3171/2015.5.PEDS1453210.3171/2015.5.PEDS14532 ↗
7. 10.1016/S1042-3680(18)30023-810.1016/S1042-3680(18)30023-8 ↗
8. 10.1038/s41582-020-0321-y10.1038/s41582-020-0321-y ↗
9. 10.1038/nm.436110.1038/nm.4361 ↗
10. 10.1016/j.cell.2023.01.01710.1016/j.cell.2023.01.017 ↗
11. 10.1074/jbc.M20810820010.1074/jbc.M208108200 ↗
12. 10.4049/jimmunol.100291010.4049/jimmunol.1002910 ↗
13. 10.1016/j.ajpath.2013.01.02810.1016/j.ajpath.2013.01.028 ↗
14. 10.1016/j.bcp.2019.11373810.1016/j.bcp.2019.113738 ↗
15. 10.1016/j.freeradbiomed.2016.08.00810.1016/j.freeradbiomed.2016.08.008 ↗
16. 10.1016/j.jconrel.2022.10.05010.1016/j.jconrel.2022.10.050 ↗
17. 10.1111/cpr.1327210.1111/cpr.13272 ↗
18. 10.1111/cpr.1320610.1111/cpr.13206 ↗
19. 10.1002/adfm.20221340110.1002/adfm.202213401 ↗
20. 10.1021/acsami.7b1792810.1021/acsami.7b17928 ↗
21. 10.1038/s41596-020-0355-z10.1038/s41596-020-0355-z ↗
22. 10.1016/j.siny.2012.06.00410.1016/j.siny.2012.06.004 ↗
23. 10.1038/s41467-018-04677-910.1038/s41467-018-04677-9 ↗
24. 10.1080/14728222.2017.135194910.1080/14728222.2017.1351949 ↗
25. 10.1042/BJ2013147810.1042/BJ20131478 ↗
26. 10.1038/s41467-019-13851-610.1038/s41467-019-13851-6 ↗
27. 10.1681/ASN.201406056010.1681/ASN.2014060560 ↗
28. 10.1186/s12886-016-0387-x10.1186/s12886-016-0387-x ↗
29. 10.1038/s41583-021-00454-810.1038/s41583-021-00454-8 ↗
30. 10.3390/ijms2203123210.3390/ijms22031232 ↗
31. 10.1073/pnas.060460710310.1073/pnas.0604607103 ↗
32. 10.1111/cns.1320310.1111/cns.13203 ↗
33. 10.1002/smll.20230232610.1002/smll.202302326 ↗
34. 10.1016/j.bioactmat.2020.11.01810.1016/j.bioactmat.2020.11.018 ↗
35. 10.1084/jem.2006120510.1084/jem.20061205 ↗
36. 10.1016/j.bcp.2018.08.01310.1016/j.bcp.2018.08.013 ↗
37. 10.1002/eji.20114167010.1002/eji.201141670 ↗
38. 10.3390/ijms1802033610.3390/ijms18020336 ↗
39. 10.1016/j.wneu.2020.09.12110.1016/j.wneu.2020.09.121 ↗
40. 10.1002/jnr.2439410.1002/jnr.24394 ↗
41. 10.1016/j.devcel.2020.09.02010.1016/j.devcel.2020.09.020 ↗
42. 10.1146/annurev.immunol.021908.13253210.1146/annurev.immunol.021908.132532 ↗
43. 10.1007/s00204-015-1472-210.1007/s00204-015-1472-2 ↗
44. 10.1126/science.107268210.1126/science.1072682 ↗
45. 10.1016/j.smim.2014.02.00910.1016/j.smim.2014.02.009 ↗
46. 10.1038/ni.164010.1038/ni.1640 ↗
47. 10.1016/j.gene.2019.02.04110.1016/j.gene.2019.02.041 ↗
48. 10.3892/mmr.2016.541110.3892/mmr.2016.5411 ↗
49. 10.1021/acs.nanolett.1c0500310.1021/acs.nanolett.1c05003 ↗
50. 10.1002/adfm.20210143510.1002/adfm.202101435 ↗
51. 10.1042/BJ2007132410.1042/BJ20071324 ↗
52. 10.14336/AD.2018.092810.14336/AD.2018.0928 ↗
53. 10.1093/eurheartj/ehac09410.1093/eurheartj/ehac094 ↗
54. 10.1186/s12974-018-1241-210.1186/s12974-018-1241-2 ↗
55. 10.1523/JNEUROSCI.1160-21.202110.1523/JNEUROSCI.1160-21.2021 ↗
56. 10.1038/sj.jcbfm.960022410.1038/sj.jcbfm.9600224 ↗
57. 10.3389/fncel.2020.0001810.3389/fncel.2020.00018 ↗
58. 10.1016/j.bbi.2019.02.00410.1016/j.bbi.2019.02.004 ↗
59. 10.1016/j.drudis.2015.05.00310.1016/j.drudis.2015.05.003 ↗
60. 10.1186/s12974-022-02456-410.1186/s12974-022-02456-4 ↗
61. 10.21769/BioProtoc.353210.21769/BioProtoc.3532 ↗